WooGene B&G Co. Ltd
WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. T… Read more
Market Cap & Net Worth: WooGene B&G Co. Ltd (018620)
WooGene B&G Co. Ltd (KQ:018620) has a market capitalization of $12.09 Million (₩17.71 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #28323 globally and #1894 in its home market, demonstrating a 0.29% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WooGene B&G Co. Ltd's stock price ₩682.00 by its total outstanding shares 25965800 (25.97 Million).
WooGene B&G Co. Ltd Market Cap History: 2015 to 2026
WooGene B&G Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $63.32 Million to $12.09 Million (-14.05% CAGR).
Index Memberships
WooGene B&G Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.01% | #1036 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.01% | #1036 of 1384 |
Weight: WooGene B&G Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
WooGene B&G Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WooGene B&G Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
WooGene B&G Co. Ltd's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $63.32 Million | $23.51 Billion | $352.76 Million | 0.00x | 0.18x |
| 2016 | $96.14 Million | $27.82 Billion | $175.43 Million | 0.00x | 0.55x |
| 2017 | $69.50 Million | $26.43 Billion | -$4.19 Billion | 0.00x | N/A |
| 2018 | $32.98 Million | $30.62 Billion | -$6.63 Billion | 0.00x | N/A |
| 2019 | $43.45 Million | $33.62 Billion | -$12.79 Billion | 0.00x | N/A |
| 2020 | $50.98 Million | $39.52 Billion | -$2.06 Billion | 0.00x | N/A |
| 2021 | $37.24 Million | $39.35 Billion | -$2.26 Billion | 0.00x | N/A |
| 2022 | $27.31 Million | $43.70 Billion | $849.57 Million | 0.00x | 0.03x |
| 2023 | $21.72 Million | $57.92 Billion | -$1.18 Billion | 0.00x | N/A |
| 2024 | $15.69 Million | $55.68 Billion | -$5.22 Billion | 0.00x | N/A |
Competitor Companies of 018620 by Market Capitalization
Companies near WooGene B&G Co. Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to WooGene B&G Co. Ltd by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3459 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6790 globally with a market cap of $1.14 Billion USD ( ₩1.67 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7061 globally with a market cap of $1.07 Billion USD ( ₩1.57 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7546 globally with a market cap of $947.54 Million USD ( ₩1.39 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3459 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩784000.00 |
| #6790 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.14 Billion | ₩80400.00 |
| #7061 | ST Pharm Co.Ltd | KQ:237690 | $1.07 Billion | ₩155800.00 |
| #7546 | Oscotec Inc | KQ:039200 | $947.54 Million | ₩58400.00 |
WooGene B&G Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, WooGene B&G Co. Ltd's market cap moved from $63.32 Million to $ 12.09 Million, with a yearly change of -14.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩12.09 Million | -17.93% |
| 2025 | ₩14.74 Million | -6.10% |
| 2024 | ₩15.69 Million | -27.76% |
| 2023 | ₩21.72 Million | -20.45% |
| 2022 | ₩27.31 Million | -26.67% |
| 2021 | ₩37.24 Million | -26.96% |
| 2020 | ₩50.98 Million | +17.35% |
| 2019 | ₩43.45 Million | +31.76% |
| 2018 | ₩32.98 Million | -52.56% |
| 2017 | ₩69.50 Million | -27.71% |
| 2016 | ₩96.14 Million | +51.83% |
| 2015 | ₩63.32 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of WooGene B&G Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.09 Million USD |
| MoneyControl | $12.09 Million USD |
| MarketWatch | $12.09 Million USD |
| marketcap.company | $12.09 Million USD |
| Reuters | $12.09 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.